11 February 2019

Dorien Feyaerts, from the research group of Van der Molen, theme Inflammatory diseases, showed that pregnancy induces a memory phenotype on endometrial natural killer cells. However, previous CMV infection is a prerequisite for this memory induction.

They published their findings in Cellular and Molecular Immunology: link.

During pregnancy, local uterine natural killer (NK) cells play an important regulatory role by ensuring correct placentation and successful pregnancy. It is known that pregnancy complications of poor placentation are at increased risk in first pregnancies. Since it has become clear that NK cells possess immune memory, it has been suggested that pregnancy could induce memory in uterine NK cells.
 
The researchers report that previous pregnancy indeed induces an increase of endometrial NK cells with a memory phenotype (LILRB1+ expression on NKG2C+ NK cells) but only when women had a CMV positive status. Multigravidae women with a CMV negative status did not show memory-like NK cells in their endometrium. This suggests that CMV seropositivity might be a prerequisite for the induction of these pregnancy-induced memory endometrial NK cells.
 
These finding opens up the exciting hypothesis that CMV primes the induction of pregnancy trained eNK cells. This prompts further research to determine how this CMV priming works and whether the observed changes would alter NK cell function in a manner beneficial for future gestations.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Laboratory Medicine

Related news items


Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs

14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more

Joyce Aarts and colleagues published in Scientific Reports about the role of TGF-β1 in (experimental) arthritis

30 March 2022

Joyce Aarts, theme Inflammatory diseases, and her colleagues published in Scientific Reports, that local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis.

read more

New EU Research project ImmUniverse

27 February 2020 In this project (31 mEURO), RIMLS and RIHS researchers collaborate with 25 European partners on dissecting common disease mechanisms of Ulcerative Colitis and Atopic Dermatitis. read more

Researchers investigate how stem cells affect the immune system

18 February 2020 RIMLS researchers Irma Joosten and Renate van der Molen, participating in an European study into the treatment of brain damage in premature babies. Is it possible to limit or even partly repair the damage with stem cells? They focus primarily on the effect of those stem cells on the immune system. read more

It is raining Horizon 2020 grants for RIMLS researchers

15 August 2019 Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available and running from 2014 to 2020. This summer, no less than 8 proposals for the Radboudumc have been accepted, 4 of them even as a coordinator. read more

TNFAIP3/A20 protein: the gatekeeper in inflammation and autoimmunity

27 August 2018 Paulo Urbano and Hans Koenen, theme Inflammatory diseases, recently published an article in the Journal of Allergy and Clinical Immunology (JACI). read more